What tests do I need right after being diagnosed with Esophageal Cancer

Esophageal CancerMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Tests You Need After an Esophageal Cancer Diagnosis

After being diagnosed with esophageal cancer, your medical team will order several important tests to understand your cancer's stage, type, and characteristics. These tests help determine your treatment options and prognosis. Here's what to expect:

Imaging Tests (To See How Far the Cancer Has Spread)

According to the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers, your doctors will typically order:

FDG-PET/CT scan (preferred)

  • This combines two imaging techniques: PET (positron emission tomography) shows metabolic activity, and CT provides detailed cross-sectional images
  • Helps detect if cancer has spread to distant organs like lungs, liver, or bones
  • Usually done 5-8 weeks after any initial treatment

Chest and Abdominal CT with contrast

  • Provides detailed images of your chest and abdomen
  • Shows the size and location of the tumor and involvement of nearby structures
  • May include pelvis imaging if clinically indicated

Endoscopy and Biopsy (To Examine the Tumor Directly)

Upper Endoscopy (EGD - Esophagogastroduodenoscopy)

  • A thin, flexible tube with a camera is passed down your throat to visualize the tumor
  • Your doctor will carefully measure the tumor's location, length, and how much of the esophagus it encircles
  • Multiple biopsies (6-8 tissue samples) are taken from the tumor for pathologic examination
  • This is essential for confirming the diagnosis and determining the cancer type

Pathology Testing (Understanding Your Cancer's Characteristics)

This is critical information that guides treatment decisions:

Histologic Type

  • Determines if you have adenocarcinoma (develops from glandular cells, often in the lower esophagus) or squamous cell carcinoma (develops from flat cells lining the esophagus)
  • Different types may respond differently to treatment

Tumor Grade

  • Describes how abnormal the cancer cells look under the microscope
  • Helps predict how aggressively the cancer may behave

Biomarker Testing (According to NCCN Guidelines, these are now recommended for all newly diagnosed patients):

  • MSI/MMR Testing (Microsatellite Instability/Mismatch Repair deficiency)

    • If your tumor is MSI-high or MMR-deficient, you may be eligible for immunotherapy options
  • PD-L1 Testing (Programmed Death-Ligand 1)

    • Helps determine if immunotherapy might be effective for your cancer
  • HER2 Testing (Human Epidermal Growth Factor Receptor 2)

    • If positive, targeted therapy with trastuzumab may be an option
  • CLDN18.2 Testing (Claudin 18.2)

    • A newer biomarker that may predict response to certain therapies
  • NGS (Next-Generation Sequencing) may be considered

    • Analyzes multiple genes simultaneously to identify mutations that could guide treatment

Lymph Node Assessment

Your pathology report should document:

  • The number of lymph nodes examined (at least 16 regional lymph nodes should be assessed)
  • Whether cancer has spread to lymph nodes
  • This information is crucial for staging and treatment planning

Timeline and Next Steps

After these tests are completed, your oncology team will:

  1. Determine your cancer's stage (how far it has spread)
  2. Assess whether you're medically fit for surgery
  3. Discuss treatment options, which according to NCCN Guidelines may include:
    • Preoperative chemoradiation (chemotherapy + radiation before surgery) - often preferred for locally advanced disease
    • Esophagectomy (surgical removal of the esophagus)
    • Definitive chemoradiation (if you decline surgery or aren't a surgical candidate)

Questions to Ask Your Healthcare Team

  1. What type and stage of esophageal cancer do I have?
  2. What do my biomarker results (MSI, PD-L1, HER2, CLDN18.2) mean for my treatment options?
  3. Am I a candidate for surgery, and if so, when would it be scheduled?
  4. What is the recommended treatment plan for my specific cancer stage and characteristics?
  5. Are there any clinical trials I might be eligible for based on my biomarker results?
  6. What are the potential side effects of my recommended treatment?

Important Note

The specific tests and their timing may vary based on your individual situation, overall health, and whether you've already had any initial treatment. Your oncology team will customize this approach for your particular case.

According to the NCCN Guidelines, a multidisciplinary team approach—involving your oncologist, surgeon, radiation oncologist, and gastroenterologist—is recommended to develop the best treatment plan for you.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: